In MLL-rearranged leukemia, the MLL-AF9 fusion protein aberrantly recruits transcriptional and epigenetic modifiers, including DOT1L, BCOR, and CBX8, disrupting normal hematopoietic gene regulation. Here, KMT2A is linked to leukemia.